Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 5Thoracic 3Gynecologic 1

Conditions

Uterine Cervical Neoplasms 12Ovarian Neoplasms 3Gestational Trophoblastic Disease 2Endometrial Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Melanoma 1Liver Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Cervical Cancer Metastatic 1Carcinoma, Non-Small-Cell Lung 1Advanced Cervical Cancer 1

Interventions

Carboplatin 19Paclitaxel 17Cisplatin 9Cyclophosphamide 8Gemcitabine 7Bevacizumab 6Topotecan 5pembrolizumab 4olaparib 4liposomal doxorubicin 4durvalumab 4Letrozole 4Interleukin-2 4Drug Therapy 4Doxorubicin 4Albumin-Bound Paclitaxel 4rucaparib 3fludarabine 3chiauranib 3cemiplimab 3camrelizumab 3Therapeutics 3Itraconazole 3Injections 3Hyperthermic Intraperitoneal Chemotherapy 3Everolimus 3pazopanib 2iniparib 2eprenetapopt 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × toripalimab × Gynecologic × Clear all
NCT07363330 2026-01-26

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Zhongnan Hospital

Phase 2 Not yet recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡